eprf

J Med Virol doi: 10

  • by

J Med Virol doi: 10.1002/jmv.25882. 2019, enzyme-linked immunosorbent assay, intravenous immunoglobulins, plaque decrease neutralization check, SARS Overview Convalescent plasma (CP) therapy continues to be used… Read More »J Med Virol doi: 10

FASEB J

  • by

FASEB J. LTBP-1 appearance increased through the initial 12 EGFR-IN-7 d in lifestyle, appeared to stay continuous between d 12 and EGFR-IN-7 24, and dropped… Read More »FASEB J

No

  • by

No. controls. Findings We report broad serological profiles within the cohort, detecting antibody binding to other human coronaviruses. 202(>99%) participants experienced SARS-CoV-2 specific antibodies, with… Read More »No

Importantly, whole characterization of the viral epitopes and their portability between DENV serotypes open fresh methods to vaccine advancement

  • by

Importantly, whole characterization of the viral epitopes and their portability between DENV serotypes open fresh methods to vaccine advancement. Dengue infections (DENVs) are significant mosquito-transmitted… Read More »Importantly, whole characterization of the viral epitopes and their portability between DENV serotypes open fresh methods to vaccine advancement